124
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study

, , , ORCID Icon, , , ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, , & show all
Pages 589-595 | Published online: 28 Feb 2020

References

  • Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry. 2005;62(6):593. doi:10.1001/archpsyc.62.6.59315939837
  • Kessler RC, Bromet EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013; 34(1):119–138. doi:10.1146/annurev-publhealth-031912-11440923514317
  • Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-V). Washington DC: American Psychiatric Association; 2013/ doi:10.1176/appi.books.9780890425596.910646
  • Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Washington DC: American Psychiatric Association ; 1994. doi10.1176/appi.books.9780890423349
  • Nair V, Ayers E, Noone M, Johnson B, Verghese J. Depressive symptoms and mild cognitive impairment: results from the Kerala-Einstein Study. J Am Geriatr Soc. 2014;62(1):197–199. doi:10.1111/jgs.1262825180388
  • Ayers E, Shapiro M, Holtzer R, Barzilai N, Milman S, Verghese J. Symptoms of apathy independently predict incident frailty and disability in community-dwelling older adults. J Clin Psychiatry. 2017;78(5):e529–e536. doi:10.4088/jcp.15m1011328406265
  • Baune BT, Sluth LB, Olsen CK. The effects of vortioxetine on cognitive performance in working patients with major depressive disorder: a short-term, randomized, double-blind, exploratory study. J Affect Disord. 2018;229:421–428. doi:10.1016/j.jad.2017.12.05629331703
  • Solé B, Jiménez E, Torrent C, et al. Cognitive impairment in bipolar disorder: treatment and prevention strategies. Int J Neuropsychopharmacol. 2017;20(8):670–680. doi:10.1093/ijnp/pyx03228498954
  • Solé E, Garriga M, Valentí M, Vieta E. Mixed features in bipolar disorder. CNS Spectr. 2017;22(2):134–140. doi:10.1017/s109285291600086928031070
  • Bonnín CM, Martínez-Arán A, Torrent C, et al. Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord. 2010;121(1–2):156–160. doi:10.1016/j.jad.2009.05.01419505727
  • Martino DJ, Marengo E, Igoa A, et al. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study. J Affect Disord. 2009;116(1–2):37–42. doi:10.1016/j.jad.2008.10.02319033081
  • Evans VC, Iverson GL, Yatham LN, Lam RW. The relationship between neurocognitive and psychosocial functioning in major depressive disorder. J Clin Psychiatry. 2014;75(12):1359–1370. doi:10.4088/jcp.13r0893925551235
  • Jha M, Teer R, Minhajuddin A, Greer T, Rush A, Trivedi M. Daily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder. NDT. 2017;13:803–813. doi:10.2147/ndt.s128407
  • Castellano S, Ventimiglia A, Salomone S, et al. Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors improve cognitive function in partial responders depressed patients: results from a Prospective Observational Cohort Study. CNSNDDT. 2016;15(10):1290–1298. doi:10.2174/1871527315666161003170312
  • Popovic D, Vieta E, Fornaro M, Perugi G. Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants. J Affect Disord. 2015;173:211–215. doi:10.1016/j.jad.2014.11.00825462418
  • Hamilton M. Development of a rating scale for primary depressive illness. Br J Clin Psychol. 1967;6(4):278–296. doi:10.1111/j.2044-8260.1967.tb00530.x
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. doi:10.1136/jnnp.23.1.5614399272
  • Beck AT, Ward CH, Mendelson M, Mock J, Erbauch J. Beck depression inventory. Arch Gen Psychiatry. 2011. doi:10.1037/t00741-000
  • Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psychiatr Res. 1975;12(3):189–198. doi:10.1016/0022-3956(75)90026-61202204
  • Nasreddine ZS, Phillips NA, Bédirian V, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–699. doi:10.1111/j.1532-5415.2005.53221.x15817019
  • Rey A. L’examen Clinique En Psychologie. Paris: Presses Universitaires de France; 1958.
  • Wechsler D. WAIS-R Manual. New York: Psychological Corporation; 1981.
  • Coco M, Platania S, Castellano S, et al. Memory, personality and blood lactate during a judo competition. Sport Sci Health. 2018;14(3):547–553. doi:10.1007/s11332-018-0458-x
  • Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55(11):1621–1626. doi:10.1212/wnl.55.11.162111113214
  • Rosa AR, Sánchez-Moreno J, Martínez-Aran A, et al. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3(1):5. doi:10.1186/1745-0179-3-517555558
  • Salagre E, Solé B, Tomioka Y, et al. Treatment of neurocognitive symptoms in unipolar depression: a systematic review and future perspectives. J Affect Disord. 2017;221:205–221. doi:10.1016/j.jad.2017.06.03428651185
  • Forcada I, Mur M, Mora E, Vieta E, Bartrés-Faz D, Portella MJ. The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder. Eur Neuropsychopharmacol. 2015;25(2):214–222. doi:10.1016/j.euroneuro.2014.07.01825172270
  • Knight MJ, Air T, Baune BT. The role of cognitive impairment in psychosocial functioning in remitted depression. J Affect Disord. 2018;235:129–134. doi:10.1016/j.jad.2018.04.05129655074
  • Martínez-Arán A, Vieta E, Reinares M, et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. AJP. 2004;161(2):262–270. doi:10.1176/appi.ajp.161.2.262
  • Martinez-Aran A, Vieta E, Colom F, et al. Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord. 2004;6(3):224–232. doi:10.1111/j.1399-5618.2004.00111.x15117401
  • Martinez-Aran A, Vieta E, Torrent C, et al. Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord. 2007;9(1–2):103–113. doi:10.1111/j.1399-5618.2007.00327.x17391354
  • Woo YS, Rosenblat JD, Kakar R, Bahk W-M, McIntyre RS. Cognitive deficits as a mediator of poor occupational function in remitted major depressive disorder patients. Clin Psychopharmacol Neurosci. 2016;14(1):1–16. doi:10.9758/cpn.2016.14.1.126792035
  • Knight MJ, Baune BT. Executive function and spatial cognition mediate psychosocial dysfunction in major depressive disorder. Front Psychiatry. 2018;9:539. doi:10.3389/fpsyt.2018.0053930420817
  • Salagre E, Grande I, Solé B, Sanchez-Moreno J, Vieta E. Vortioxetine: a new alternative for the treatment of major depressive disorder. Revista de Psiquiatría y Salud Mental. 2018;11(1):48–59. doi:10.1016/j.rpsmen.2018.02.00528800937